Coronavirus Disease (COVID-19) Updates

In response to the current outbreak of coronavirus disease (COVID-19) that was first reported from Wuhan, China, on December 31, 2019, Charles River has assembled a global team of internal experts who are closely monitoring the COVID-19 outbreak and its impact on employee safety and our business operations. To keep clients informed, we will post updates to this web page.

Charles River corporate headquarters

July 24, 2020 – As events related to COVID-19 continue to unfold, I wanted to provide an update on our status. Charles River remains operational across all sites, adapting to developments as they occur. We are still monitoring the outbreak with our internal and external experts and assessing the impact on employee safety and business operations. Our locations around the world are doing an excellent job of providing protection for their employees while still meeting clients’ needs for research products and services.

While governments at various levels have begun implementing a “return to business,” we recognize the risk of infection remains present, and in some locations, cases are increasing. To help prevent the spread of the virus while maintaining continued operations during this period, the following safety measures remain in place:

  • Employees work from home when possible
  • Strict visitor policies
  • Restrictions on all non-essential business travel
  • Modified employee work schedules to create “time and distance” and separation of staff
  • Physical distancing practices
  • Enhanced daily cleaning of common touch points (doorknobs, break areas, etc.)
  • Reminders of good hygiene practices
  • Face coverings are required for employees and visitors with applicable government guidance
  • Employee self-monitoring for illness symptoms
  • Tracking and contact tracing of COVID-19 cases
  • Return to work and self-quarantine guideline documents

Our global and site Business Continuity Plans are active, up to date, and helping our site-based operations, as well as associated logistics and support, to continue to meet our clients’ needs for planned and new projects, including work supporting COVID-19 research efforts.

For the latest business continuity updates, continue to visit this page. For continued learning, our digital education page has many helpful resources for researchers. If you have any other questions, please reach out to your sales representative.

Contact Us

Call us at:
United States and Canada: +1.877.CRIVER1 (+1.877.274.8371)

All other locations: 888.319.5343

Hours of coverage:
6 a.m.-6 p.m. ET

Email us at:
[email protected]


Related Resources

Business Operations Updates:

Compliance and Quality Assurance

Novel Coronavirus and Research Animals
(Updated April 28, 2020)

Visitor Notice
(Updated July 14, 2020)

COVID-19 UK Statement